Drug Detail:Inpefa (Sotagliflozin)
Generic Name: sotagliflozin 200mg
Drug Class: Miscellaneous cardiovascular agents
Drug Detail:Inpefa (Sotagliflozin)
Generic Name: sotagliflozin 200mg
Drug Class: Miscellaneous cardiovascular agents
Assess volume status and, if necessary, correct volume depletion prior to initiation of INPEFA [see Warnings and Precautions (5.2) and Use in Specific Populations (8.5, 8.6)].
Assess renal function prior to initiation of INPEFA and then as clinically indicated [see Warnings and Precautions (5.2)].
For patients with decompensated heart failure, dosing may begin as soon as the patient is hemodynamically stable, including during hospitalization or urgent outpatient treatment or immediately upon discharge.
The recommended starting dose of INPEFA is 200 mg orally once daily not more than one hour before the first meal of the day.
Up-titrate after at least 2 weeks to 400 mg orally once daily as tolerated [see Clinical Studies (14)]. Down-titrate to 200 mg as necessary [see Adverse Reactions (6.1), Warnings and Precautions (5) and Use in Specific Populations (8.6)].
Withhold INPEFA at least 3 days, if possible, prior to major surgery or procedures associated with prolonged fasting. Resume INPEFA when the patient is clinically stable and has resumed oral intake [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)].